Endovascular treatment of a tuberculous infected aneurysm of the descending thoracic aorta: A word of caution  by Labrousse, Louis et al.
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An infected aneurysm of the thoracic aorta due to mycobacterium tuberculosis is an unusual entity for which the classical
treatment is antituberculosis chemotherapy and open-chest surgery. Recent improvements in endovascular treatments
have led to their proposed use for infected aneurysms in patients for whom open surgery poses too high a risk. We report
on a 68-year-old man with a tuberculous aortic aneurysm who had been treated with an endoprosthesis and antituber-
culosis chemotherapy. His clinical and radiological follow-up was uneventful and led to the discontinuation of
pharmacological treatment after 16 months. However, a recurrence of the infection led to a fatal aortic rupture 4 months
after discontinuation of therapy. (J Vasc Surg 2007;46:786-8.)Endovascular aortic repair of infected thoracic aortic
lesions has been introduced in an attempt at reducing
operative morbi-mortality. Although only a few cases have
been reported, this innovative option is increasingly gain-
ing acceptance and is becoming, for some surgeons, the
first option for the treatment.1,2 We report a rare case of the
endovascular treatment of an infected aneurysm of the tho-
racic aorta due to mycobacterium tuberculosis. Although
initial control of disease was successfully attained, recur-
rence of the infection 4 months after discontinuation of the
antitubercular drug therapy led to a fatal aortic rupture.
CASE REPORT
A 68-year-old man was admitted to the department of
pulmonary disease for a giant tuberculous cavern (involving the
entire upper left lobe), associated with a cutaneous fistula. His
history included tobacco use, chronic pulmonary insufficiency
with hypoxia, hypertension, and angina. Recent signs were
fever, weight loss, and severe asthenia. Sputum cultures were
positive for mycobacterium tuberculosis and susceptible to
usual antituberculosis drugs. Thus, a classic therapy was started
with pyrazinamide, isoniazid, rifampin, and ethambutol. After 2
months, the treatment was switched to a double therapy of
isoniazid and rifampin. Two months later, the patient received
an emergency transfer to our department for a large blood
effusion from the cutaneous fistula. A computed tomography
(CT) scan showed an aneurysm of the isthmic part of the aorta,
in contact with the pulmonary cavern. The necks of the aneu-
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786rysm were suitable for an endovascular approach (proximal
aortic diameter: 27 mm, distal aortic diameter: 25 mm). Be-
cause of the patient’s poor condition, an emergent endovascular
procedure was planned. In the operating room, the patient was
given general anesthesia and an aortic angiography confirmed
the diagnosis (Fig 1). After right femoral surgical access was
obtained, the endoprosthesis (Talent, Medtronic Inc, Minne-
apolis, Minn, diameter 30 mm, length 11 cm) was tracked into
the distal aortic arch over a stiff guidewire, under fluoroscopic
guidance.
The endoprosthesis was deployed across the tuberculous
aneurysm, overlapping 3 cm of healthy aorta both distally and
proximally. Balloon inflation at both ends of the endoprosthesis
completed the procedure. A final angiogram indicated total
exclusion of the aortic aneurysm. After a short postoperative
course (extubation time: 3 hours, ICU stay: 1 day) the patient
was discharged on postoperative day 8. A new complete treat-
ment of tuberculosis was started with the same previous four
drugs for 2 months followed by the same two-drug therapy. The
patient’s fever resolved quickly, with a normalization of the
white blood cell count and inflammatory markers.
Four months later, the patient underwent a radical nephrectomy
for a clear cell renal carcinoma. No associated treatment was planned
for the tumor. Postoperative recovery was particularly long because of
chronic asthenia, and the patient declined any new surgical therapy for
his pulmonary cavitation, such as thoracoplasty and/or pulmonary
resection.
Follow-up was performed every 3 months by clinical and
sputum examination and thoraco-abdominal CT scan. At every
assessment, the CT scan showed a perfect exclusion of the
aneurysm with no abnormal features compared with the preop-
erative CT scan (Fig 2). The patient’s recovery was uneventful,
with a weight gain of 4 kg and no microbiological evidence of
persistent infection. White blood cell counts were below
8500/ml and C-reactive protein (CRP) 25 U/ml (normal:
below 10), compared with a preoperative level at more than 80
U/ml. The antituberculosis treatment was stopped (total dura-
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lavages and sputum cultures were negative.
The next CT scan 3months later was also without new specific
abnormalities. However, 1 month later, the patient was referred to
another hospital for collapse and thoracic pain. Diagnosis of aortic
rupture wasmade based on the chest X-ray and the patient died few
hours after admission. A review of the previous CT scan confirmed
the absence of preliminary features of a recurrence of the disease.
Fig 1. Perioperative angiogram of the tuberculous aneurysm of
the proximal part of the descending aorta.
Fig 2. Postoperative computed tomography (CT) and C
the endoprosthesis and the exclusion of the tuberculou
endoprosthesis and the pulmonary cavitation.DISCUSSION
A tuberculous aneurysm of the thoracic aorta is a rare
entity resulting from either direct extension to the vessel or
hematologic contamination.3 In our patient, the mecha-
nism seems to have been mainly attributable to the contig-
uous extension from a cavernous lesion in the left superior
lobe of the lung. This mechanism explains the sacciform
feature of the aneurysm, which was in fact a pseudoaneu-
rysm. As in previously published cases,3,4 the aneurysm
appeared in spite of ongoing adjusted antituberculosis che-
motherapy, which probably reflects poor drug penetration
into the necrotic tissue.9 In addition, the coexistent renal
cancer may have played a role by compromising the pa-
tients’ immune status.
The traditional approach to a tuberculous infected
aneurysm of the descending thoracic aorta is antitubercu-
losis chemotherapy combined with surgery, which involves
extensive excision and debridement of the infected field,
with in situ prosthetic repair.3-8 Surprisingly, excellent re-
sults in this difficult setting have been reported. An exten-
sive review of the literature (PubMed, National Library of
Medicine) shows that 95% (19 of 20 published cases) of
patients surgically treated for a descending tuberculous
aneurysm survived.3-8 However, the follow-up has been
usually short (less than 18 months) and never exceeded 3
years. Even if published open-chest surgical series are satis-
factory in terms of morbidity and mortality, the clinical
presentation of patients such as ours is usually challenging,
with acute hemorrhage, age over 60 years, immunosup-
pressive status, malnutrition, and weight loss.3,4 In such
patients, a less invasive endovascular option is attractive.9,10
The main problem with the endovascular approach is
the impossibility of performing extensive excision and de-
sed three-dimensional reconstruction of the thorax with
urysm. Note the close anatomical contact between theT-ba
s ane
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surgical strategy. This debridement likely plays a key role in
eliminating necrotic tissue and, thus, improving antimyco-
bacterial drug efficiency.3,5,8 Thus, the potential benefit
from this minimally invasive approach has to be compared
with the obvious, higher risk of infection recurrence. Our
patient’s debilitated status (and the patient’s decision) led
us to avoid a surgical procedure on the residual cavern,
which was probably the main cause of the recurrence of the
infection. Such a situation is likely different from the previ-
ously published cases of successful endovascular treatment
of tuberculous aneurysms of the abdominal10 and thoracic11
aorta. In the two abdominal cases, the lesions did not have
cutaneous fistulae. The usual antituberculous treatment is
more effective in such cases than when there are large
residual cavitations.3,10 This difference due to the presence
of cavitations is confirmed by a recently reported successful
treatment of a tuberculous thoracic aneurysm11 diagnosed
by microbiology in the absence of observed lung lesions in
contact with the aorta. Moreover, the follow-up of this last
patient was limited to 12 months with no late follow-up
after cessation of antimicrobial therapy. A secondary treat-
ment of tuberculous cavitations seems mandatory in this
clinical setting, and pulmonary resection is probably the
more effective therapy. Depending of patient condition and
clinical situation, the endovascular treatment should then
be considered either as a bridge to a second open chest
(curative) treatment or as a palliative “destination therapy”.
In case of palliative therapy, it seems appropriate to main-
tain lifelong antibiotic treatment when tuberculosis se-
quelae include large cavitations in contact with the aorta.
Our patient’s recurrence occurred shortly after the
discontinuation of antitubercular drug therapy. The deci-
sion to discontinue these medications was based on the
duration of therapy (16months), appropriate antimicrobial
activity, decreased levels of inflammatory markers, un-
changed imaging features, and negative results from all
bacteriological analysis. However, CRP level was not
strictly normal, and this should have been an indicator not
to discontinue oral therapy. In the literature, there is no
consensus regarding the duration of the antimicrobial ther-
apy in this specific situation. The paucity of cases makes this
decision difficult, and all authors recommend using a com-
bination of clinical, biological, and radiographic informa-
tion.3-11 Here, the CT scans did not help to predict the
recurrence. The unchanged appearance of the CT scan a
few weeks before the rupture may be due to artifacts caused
by calcifications in the cavern wall and by the stent’s bars,
which made analysis of the aortic wall and periaortic area
difficult. Thus, an erosion of the aortic wall distal to the
extremity of the endoprosthesis may have been unrecog-
nized until the new pseudoaneurysm appeared. As CT-scan
alone does not appear to provide accurate follow-up for such
infected aneurysms, another imaging technique may be use-
ful, such as In-labelled biotin scan, since it is considered to be
highly sensitive in detecting graft infection. 12 The need for
associated In-labelled biotin scan assessment will increase thecost of the follow-up, but might allow earlier diagnosis of
recurrences that may be treated either surgically (if the pa-
tient’s condition permits) or with an endovascular approach
covering a supplemental aortic segment.
CONCLUSION
In conclusion, the endovascular treatment of a tuber-
culous aneurysm of the descending aorta may offer ade-
quate temporary control but must be considered noncura-
tive, especially if the aneurysm is in contact with a residual
pulmonary lesion that is not entirely (and probably surgi-
cally) treated. Patient condition helps to distinguish those
for whom the endovascular treatment might be a bridge to
a second stage of a curative, open chest treatment from
those for whom it will be a palliative treatment with lifelong
monitoring. The classical length of the antimycobacterial
therapy may be less likely to eradicate infection in the
presence of a lesion that is in contact with a foreign body.
Chronic or even lifelong antimycobacterial treatment,
therefore, is recommended when surgical treatment of the
residual tuberculosis lesion cannot be achieved.
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